← Evidence map

ArticleScientific reports2022

A multiomics disease progression signature of low-risk ccRCC.

Philipp Strauss et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35931808